To date, widespread masking has been recommended by a number of organizations to reduce spread and personal infection risk from viruses like COVID 19. The American Academy of Pediatrics, validated this recommendation by advising all children 2 and up to wear masks. Yet quality data supporting any of these recommendations was never available. This Cochrane Review collates the available quality studies and concludes neither cloth , surgical or even N95 masks provide any significant protection to the wearer in these settings. The recommendation for public masking, while well intentioned, was wrong and should be abandoned immediately.
Friday, February 3, 2023
Tuesday, September 6, 2022
Ongoing clinical research in the area of sleep disordered breathing has shown the benefit of a multidisciplinary team in treating these disorders. Put simply, sleep disorder treatment is not a one size fits all and you need many health care providers working together to find the right care plan. These include the primary care provider, otolaryngologist, neurologist, pulmonologist, dentist/orthodontist, speech/occupational therapist and more. This paper highlights the benefits of a multi-pronged strategy.
Monday, August 29, 2022
From the start of the COVID 19 pandemic, a real ongoing concern was identifying children and adolescents who could be high risk for poor outcomes with COVID 19 infections. Asthma was presumed to be one of these conditions. However, although mucosal respiratory viruses all have the potential to trigger asthma exacerbations, high quality data consistent fails to show any increased risk of COVID 19 related complications. However, another Scottish study from last year reported higher risk for hospitalization due to asthma exacerbations after a COVID 19 infection if asthma was NOT well controlled. To put it simply, if your child has asthma make sure it is controlled.
Thursday, July 28, 2022
COVID 19 infections in children and adolescent or rarely associated with a severe respiratory illness. However, persistent respiratory symptoms have been reported in children after a COVID 19 infection. With increased awareness about "long COVID" in adults, the question could be asked does such a disease exist in children. This study attempted to answer this question by studying adolescents after COVID infection who had persistent respiratory symptoms like cough and shortness of breath. The most common conditions identified in this small cohort of children included asthma features, paradoxical vocal fold motion, deconditioning and dysautonomia.
Monday, April 4, 2022
Narcolepsy is a rare disorder associated with excessive sleepiness despite adequate sleep time. A potentially highly efficacious therapy for narcolepsy, Xywav, is complicated by a difficult dosing regimen requiring twice nightly administration for optimal effect. A new therapy in development by Avadel may provide a similar benefit in a once nightly dose.
Avadel Pharmaceuticals plc, whose marketing application for narcolepsy drug candidate FT218 is under review by the US Food and Drug Administration (FDA), presented in eight posters at World Sleep 2022. FT218 is an investigational formulation of sodium oxybate designed to be taken once at bedtime for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.
Highlights from the Poster Presentations
Wednesday, March 16, 2022
This is Sleep Awareness Week. Organizations such as the National Sleep Foundation routinely survey adults and find that sleep disorders are extraordinarily common and can significantly impact quality of life. Sleep disorders in children and adolescents, though, are vastly underrecognized with between 20-30% of young children affected by disrupted sleep and 60-70% of adolescents experiencing reduced sleep time. The effects can be numerous, including reduced cognitive function, mental health concerns, and increased metabolic and cardiovascular health risks. A pediatric sleep specialist is NOT the sleep lab doctor. A pediatric sleep clinic provides a comprehensive evaluation and treatment for all manners of sleep disorders to provide evidence based treatment recommendations for your entire health care team.
To kick off Sleep Awareness Week, the National Sleep Foundation released the results from the 2022 Sleep in America Poll. The annual survey is one of the longest running records capturing Americans’ perceptions, attitudes, and behaviors around sleep.
Poll results show:
Things you can do to help be your Best Slept Self:
Monday, March 7, 2022
Asthma is a complex respiratory disorder that significantly raises risk for ER visits and hospitalizations. Despite it's complexity, there is a consistent knowledge gap that can put patients and parents at a significant disadvantage. Following a consistent strategy grounded in evidenced based practice can make a difference in reducing chaos and preventing frequent sick visits. This study demonstrated that a focused asthma education program consistently reduced these risks.